Kristin is the national and global HCLS strategy leader at KPMG, and the global healthcare and life sciences deal advisory leader. She has 25 years of experience in research and strategy consulting and M&A diligence in medical innovation and the healthcare and life sciences industry. Her primary areas of focus are deal advisory and corporate strategy for pharmaceutical, diagnostics, and consumer health companies, investors, and medical institutions worldwide. She is a noted speaker, workshop leader, and writer in the life sciences industry. She is also a leader in clinical laboratory and medical innovation, developing product and service strategies, operations, and global deals with on-the-ground experience in North America, Latin America, Europe, Asia, India, the Middle East, and the Caribbean. Her book, Personalizing Precision Medicine, was a clinical best seller and has garnered attention worldwide for its all-inclusive and comprehensive look at diagnostics and global precision medicine. Kristin also works with health systems and affiliated organizations on their innovative services strategies, diligences, and operations, including clinical laboratory builds, health IT, hospital services, and clinical outreach strategy. Kristin is on our KPMG Restart America task force and leads the development of COVID-19 diagnostic, vaccine, and other service programs for labs, large employers, medical institutions, sports franchises, and regions seeking recovery. Previously, Kristin was at EY-Parthenon where she was a partner and the global head of Life Sciences, responsible for growing the business from a single deals-focused office to a full service global strategy practice. Earlier in her career, she helped build Health Advances, a healthcare strategy firm now part of Parexel, and was a genomics based scientist and clinical diagnostics developer at Genome Therapeutics and Genzyme/Sanofi.